Endothelial Dysfunction and Impaired Wound Healing Following Radiation Combined Skin Wound Injury

Area of Science:

• Radiation combined injury
• Endothelial dysfunction
• Wound healing

Background:

• No FDA-approved medical countermeasures exist for radiation combined injury (RCI).
• Endothelial dysfunction is a suspected contributor to poor RCI prognosis.
• Understanding RCI mechanisms is crucial for developing effective treatments.

Purpose of the Study:

• To investigate the impact of RCI on mortality, body weight, and skin wound healing.
• To evaluate early biomarkers of endothelial dysfunction, inflammation, and impaired wound healing in RCI.
• To explore potential therapeutic targets for RCI.

Main Methods:

• Mice were exposed to 9.0 Gy total-body irradiation (TBI) followed by a skin wound.
• Samples were collected on days 3, 7, and 14 post-TBI.
• Endothelial dysfunction markers were measured using ELISA; skin wound healing was assessed histologically.

Main Results:

• RCI mice exhibited increased mortality, weight loss, and delayed skin wound healing compared to controls.
• Endothelial damage and inflammation were more severe and persistent in RCI mice.
• RCI impaired granulation tissue formation, myofibroblast presence, and collagen deposition, linked to endothelial damage.

Conclusions:

• Endothelial dysfunction and inflammation significantly contribute to poor outcomes in RCI.
• Impaired wound healing in RCI is associated with endothelial damage and altered TGF-β signaling.
• Targeting endothelial dysfunction and TGF-β pathways may offer therapeutic strategies for RCI.